Trial Details
COMPLETEDBasic Information
| Clinical ID | c4556 |
|---|---|
| Identifier | NCT00329550 |
| Trial Title | Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol (CZP)|BIOLOGICAL: Certolizumab pegol (CZP)|BIOLOGICAL: Certolizumab pegol (CZP) |
Participant Information
| Sponsor | UCB Japan Co. Ltd. |
|---|---|
| City | Aichi-ken |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-05 |
|---|---|
| Primary Completion Date | 2008-04 |
| Completion Date | 2008-04 |